Back in October 2015, OncoGenx announced a phase 3 trial designed to evaluate whether the investigational treatment custirsen, when combined with cabazitaxel, improves survival in men with metastatic castrate-resistant prostate cancer.
Read MoreADT is frequently combined with radiation therapy for the treatment of men with intermediate- or high-risk prostate cancer. No evidence suggests that this treatment platform benefits patients with low- or favorable-risk disease.
Read MoreAccording to the Prostate Cancer Foundation, African American men are 64% more likely to develop prostate cancer compared with Caucasian men and are nearly 2.4 times more likely to die from the disease.
Read MoreA recent meta-analysis published in the July 2016 European Association of Urology journal found consistently higher mortality rates for patients diagnosed with localized prostate cancer who were treated with radiation rather than surgery.
Read MoreAside from non-melanoma skin cancer, prostate cancer is the most common cancer among men in the U.S., according to the Centers for Disease Control and Prevention. It is also one of the leading causes of cancer death among men of all races.
Read MoreCancer researchers have applied a comprehensive set of analytical tools to lethal cases of metastatic prostate cancer, yielding a detailed map of the complex networks of interactions among genes and proteins that enable prostate cancer cells to proliferate and evade treatment.
Read MoreMen with very high-risk prostate cancer, who are treated at hospitals with a high proportion of administered radical local treatment (radiotherapy or prostatectomy), only have half of the mortality risk of men who are treated at hospitals with the lowest proportion.
Read MoreFred Hutchinson Cancer Research Center has found that high-dose supplementation with both the trace element selenium and vitamin E increase the risk of high-grade prostate cancer.
Read MoreA newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy.
Read MoreAn enlarged prostate also known as benign prostatic hyperplasia (BPH), has been treated in various ways with one of them being the use of the dietary supplement saw palmetto.
Read MoreResearchers examined records of 9,108 obese men who underwent radical prostatectomy (removal of the prostate gland and some surrounding tissue). Among all patients, 60.4 percent underwent robotic-assisted radical prostatectomy and 39.6 percent underwent open prostatectomy.
Read MoreThe potential foundation for a next-generation therapy, called tetraaryl cyclobutane, or CB, is being studied as an option for prostate tumors that have grown resistant to current anti-androgen drugs, notably enzalutamide.
Read More
